Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy

ConclusionsThis study suggests that there is no difference on survival between patients withEGFR mutations and those without, but the patients harboringEGFR 19del mutation have survival advantage compared to those harboringEGFR L858R mutation.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research